RODRIGUEZ RAUL R
SEC CIK 1190279 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RIGL | RIGEL PHARMACEUTICALS INC | CEO, Pres, Dir | 273.4K | $690.0K | $295.8K | 16 | 2022-01-24 | 2026-09-01 |
Most active insiders at RIGL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ali-Jackson Kamil | Dir | — | $160.4K |
| 2 | MOOS WALTER H | Dir | — | $145.4K |
| 3 | Rojkjaer Lisa | EVP, Chief Medical Off | — | — |
| 4 | Santos David A | EVP, Chief Commercial Off | — | — |
| 5 | HANNAH ALISON L. | EVP, Chief Medical Off | — | — |
| 6 | Furey Raymond J. | EVP, GC, CCO, Corp Sec | — | — |
| 7 | Schorno Dean L | EVP, CFO | — | — |
| 8 | Frohlich Mark W | Dir | — | — |
| 9 | Wasman Jane | Dir | — | — |
| 10 | LAPOINTE ANTHONY GREGG | Dir | — | — |
| 12 | RODRIGUEZ RAUL R | CEO, Pres, Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 18:59 | 2026-09-01 | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, Pres, Dir | F - Tax | $47.50 | -2,424 | 273.4K | -0.9% | -$115.1K | |
| 2026-06-03 18:01 | 2026-06-01 | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, Pres, Dir | F - Tax | $29.86 | -2,424 | 279.6K | -0.9% | -$72.4K | |
| 2026-02-19 | 2026-02-17 | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, Pres, Dir | A - Grant | $0.00 | +53.9K | 282.0K | +24% | $0 | |
| 2026-02-12 | 2026-02-10 | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, Pres, Dir | F - Tax | $34.62 | -7,607 | 228.1K | -3% | -$263.4K | |
| DM | 2026-02-04 | 2026-01-26+ | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, Pres, Dir | F - Tax | $36.84 | -84.7K | 245.2K | -26% | -$3.12M |
| DM | 2026-02-04 | 2026-01-26 | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, Pres, Dir | M - OptEx | $27.40 | +80.0K | 280.5K | +40% | +$2.19M |
| M | 2025-02-06 | 2025-02-04+ | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, Pres, Dir | S - Sale | $21.40 | -9,352 | 239.5K | -4% | -$200.1K |
| D | 2025-01-31 | 2025-01-29 | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, Pres, Dir | A - Grant | $0.00 | +42.3K | 248.8K | +20% | $0 |
| DM | 2025-01-28 | 2025-01-24 | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, Pres, Dir | F - Tax | $22.17 | -88.2K | 206.5K | -30% | -$1.95M |
| DM | 2025-01-28 | 2025-01-24 | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, Pres, Dir | M - OptEx | $21.40 | +90.0K | 249.7K | +56% | +$1.93M |
| M | 2024-02-06 | 2024-02-02+ | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, Pres, Dir | S - Sale | $1.14 | -52.9K | 2.07M | -2% | -$60.1K |
| D | 2024-01-25 | 2024-01-23 | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, Pres, Dir | A - Grant | $0.00 | +400.0K | 2.09M | +24% | $0 |
| D | 2023-02-07 | 2023-02-06 | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, Pres, Dir | S - Sale | $1.75 | -20.3K | 1.68M | -1% | -$35.6K |
| D | 2023-02-07 | 2023-01-26 | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, Pres, Dir | A - Grant | $0.00 | +300.0K | 1.70M | +21% | $0 |
| 2022-06-13 | 2022-06-09 | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, Pres, Dir | P - Purchase | $0.69 | +1.00M | 1.39M | +255% | +$690.0K | |
| D | 2022-01-26 | 2022-01-24 | RIGL | RIGEL PHARMACEUTICALS INC | RODRIGUEZ RAUL R | CEO, Pres, Dir | A - Grant | $0.00 | +200.0K | 391.8K | +104% | $0 |
Purchase Sale Sale after option exercise All abbreviations